Caspase 3 and Cleaved Caspase 3 Expression in Tumorogenesis and Its Correlations with Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis

Abstract

Head and neck cancer (HNC) is an ascending and agressive disease. The search for new molecular markers is emerging to solve difficulties in diagnosis, risk management, prognosis and effectiveness of treatments. Proteins related to apoptotic machinery have been identified as potential biomarkers. Caspase 3 is the main effector caspase and has a key role in apoptosis. The objective of this systematic review and meta-analysis is to review studies that analyze changes in Caspase 3 and Cleaved Caspase 3 expression both in oral premalignant disorders (OPMD) as well as in head and neck cancer (HNC). This study also proposes to review the prognostic values associated with HNC according to the expression of Caspase 3. Medline (via PubMed), EMBASE, Scopus, Cochrane, Web of Science and Grey Literature Database were screened from inception to june of 2022 and 18 studies were selected and 8 were included in the prognostic meta-analysis. Results related to the comparison of Caspase 3 expression demonstrated similar expression of Caspase 3 in HNC, with an average of 51.9% (9.5-98.1) showing high/moderate expression compared to 45.7% (14.6-84.7) in OPMD. Of interest, Cleaved Caspase 3 resulted incresed in HNC when compared with OPMD, being 73.3% (38.6-88.3) versus 22.9% (7.1-38.7). Pooled Fixed effect of HR values (95% CI) for OS related to Caspase 3 IHC expression in HNC patients was 1.48 (95% CI 0.95-2.28); also, the rate of heterogeneity was low, as revealed by I2 = 31%. For DFS was 1.07 (95% CI 0.79-1.45) with I2 = 0% and DSS showed a HR of 0.88 (95% CI 0.69-1.12) with I2 = 37%. Caspase 3 and Cleaved Caspase 3 expression could be linked with malignancy progression, but the expression of Caspase 3 did not influence the prognosis of patients with HNC.

Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice

“…The most efficacious dose of Nic-SMEDDS, 100 mg/kg, bid, induced the greatest Ki-67 reduction, suggesting greatest inhibition of tumor cell proliferation ( Figure 3a and b ). Correlating with Ki-67 staining, treatment with all doses of Nic-SMEDDS and NEN increased the levels of activated Caspase-3 protein 29 in PDX tissues, indicating an increased number of activated apoptotic cells; the greatest effect was similarly seen with the most efficacious dose of Nic-SMEDDS at 100 mg/kg, bid ( Figure 3c and d ). We additionally detected cleaved Caspase-3 protein levels in the PDX tissues, harvested at the treatment endpoint.…”

Novel Carrier-Free Nanodrug Enhances Photodynamic Effects by Blocking the Autophagy Pathway and Synergistically Triggers Immunogenic Cell Death for the Efficient Treatment of Breast Cancer

“…Meanwhile, the influence of Ce6@CQ on tumor cells was further investigated by immunoblotting analysis (Figure B–D). As a vital mediator of apoptosis, Caspase 3 is cleaved at an aspartate in order to produce cleaved caspase 3 (c-Caspase 3), which is accountable for morphological and biochemical changes in apoptosis. , The protein expression of c-Caspase 3 maintained a low level in dark groups, while c-Caspase 3 was significantly activated in light groups. The 4T1 cells treated by Ce6@CQ had the highest expression level of c-Caspase 3 compared to others, suggesting that the apoptotic pathway was triggered intensively.…”

Dexmedetomidine ameliorates acute brain injury induced by myocardial ischemia-reperfusion via upregulating the HIF-1 pathway

“…Among them, caspase-3 is the primary executor of apoptosis, and its activation promotes the degradation of DNA-repairing and cytoskeletal proteins, leading to cell morphological changes and DNA damage, culminating in cell apoptosis (36). Cleaved caspase-3, the active form of caspase-3, is responsible for apoptosis-related morphological and biochemical changes in cells (50). It has been shown that myocardial IR induced significant neuronal apoptosis, as evidenced by an increase in TUNEL-positive cells (31) and upregulation of cleaved caspase-3 expression in brain tissue (30,38).…”